Rising's Generic Price Fixing Settlement Follows Bankruptcy, Cooperation With DOJ

 
• By Brenda Sandburg
  
WASHINGTON, DC - MARCH 2018: Headquarters of the U.S. Justice Department. Art Deco aluminum torcheres at doorway. Renamed the Robert F. Kennedy Department of Justice Building in 2001.
Rising Pharmaceuticals is the second company to settle generic price fixing probe with the Department of Justice
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics